Condition
Runner's Knee
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 3 (1)
Trial Status
Completed2
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07475663Phase 3Completed
Counterpain PXM Versus Diclofenac Versus Piroxicam
NCT06086860Not ApplicableCompletedPrimary
Effects of Mulligan Mobilization With and Without Dry Needling in Runner's Knee
NCT05656755Not ApplicableUnknownPrimary
Strengthening Running Program in Novice Runners
NCT04642248Phase 1UnknownPrimary
A Comprehensive Analysis for Identification of Risk Factors for Running-Related Injuries
Showing all 4 trials